0001104659-24-036284.txt : 20240319 0001104659-24-036284.hdr.sgml : 20240319 20240319195025 ACCESSION NUMBER: 0001104659-24-036284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240309 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sawicki Mark W CENTRAL INDEX KEY: 0001848218 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34632 FILM NUMBER: 24765835 MAIL ADDRESS: STREET 1: 3303 LAKEPOINTE DRIVE CITY: BELMONT STATE: NC ZIP: 28012 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cryoport, Inc. CENTRAL INDEX KEY: 0001124524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880313393 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 112 WESTWOOD PLACE, SUITE 350 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: (949) 232-1900 MAIL ADDRESS: STREET 1: 112 WESTWOOD PLACE, SUITE 350 CITY: BRENTWOOD STATE: TN ZIP: 37027 FORMER COMPANY: FORMER CONFORMED NAME: CRYOPORT SYSTEMS LLC DATE OF NAME CHANGE: 20010614 FORMER COMPANY: FORMER CONFORMED NAME: CRYOPORT SYSTEMS INC DATE OF NAME CHANGE: 20000923 4 1 tm249281-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-09 0 0001124524 Cryoport, Inc. CYRX 0001848218 Sawicki Mark W C/O CRYOPORT INC. 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 0 1 0 0 Chief Scientific Officer 0 Common Stock 2024-03-09 4 M 0 2666 0 A 75791 D Common Stock 2024-03-11 4 S 0 1418 16.3524 D 74373 D Common Stock 2024-03-15 4 S 0 1312 15.4322 D 73061 D Common Stock 2024-03-15 4 A 0 5750 0 A 78811 D Restricted Stock Rights 2024-03-09 4 M 0 2666 0 D Common Stock 2666 2667 D Stock Option (right to buy) 16.70 2024-03-15 4 A 0 11500 0 A 2031-03-15 Common Stock 11500 11500 D Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024. /s/ Mark Sawicki 2024-03-19